Bariatric surgery in individuals with human immunodeficiency virus and type 2 diabetes: a case series.

Background: The efficacy and safety of bariatric surgery have not been fully elucidated in patients affected with human immunodeficiency virus. Although adjustable gastric banding and sleeve gastrectomy are starting to be used in patients with human immunodeficiency virus, there are limited descriptions of the outcomes of type 2 diabetes mellitus in individuals who are human immunodeficiency virus positive and undergoing these procedures.

Case Presentation: We have evaluated retrospectively three patients who underwent adjustable gastric banding or sleeve gastrectomy, the effect in weight reduction and glycemic control as well as its impact on human immunodeficiency virus management.

Prevention of atherosclerosis in patients living with HIV.

Unlabelled: INVESTIGATIONAL PRODUCT: Rosuvastatin (Crestor; Astra Zeneca).

Active Ingredients: Rosuvastatin (5 mg).

Study Title: Prevention of Atherosclerosis in Patients Living with HIV.